| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
7,084 |
5,930 |
$181K |
| 99213 |
|
3,737 |
3,300 |
$71K |
| 99204 |
|
1,065 |
1,022 |
$44K |
| 99215 |
Prolong outpt/office vis |
1,217 |
1,091 |
$44K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
355 |
342 |
$16K |
| 99203 |
|
615 |
600 |
$15K |
| 93306 |
|
283 |
244 |
$14K |
| 71045 |
|
7,943 |
5,611 |
$13K |
| 99310 |
Prolong nursin fac eval 15m |
637 |
325 |
$13K |
| 99233 |
Prolong inpt eval add15 m |
928 |
232 |
$12K |
| 70450 |
|
1,065 |
929 |
$10K |
| 74176 |
|
291 |
275 |
$8K |
| 74177 |
|
218 |
209 |
$8K |
| 88305 |
|
495 |
470 |
$8K |
| 99223 |
Prolong inpt eval add15 m |
251 |
214 |
$7K |
| 99232 |
|
422 |
130 |
$6K |
| 71046 |
|
1,240 |
1,157 |
$6K |
| 93970 |
|
246 |
228 |
$4K |
| 99309 |
|
197 |
143 |
$4K |
| 71250 |
|
168 |
165 |
$4K |
| 93010 |
|
796 |
739 |
$3K |
| 96372 |
|
381 |
318 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
254 |
241 |
$2K |
| 99205 |
Prolong outpt/office vis |
24 |
24 |
$982.91 |
| 93005 |
|
275 |
267 |
$754.98 |
| 73562 |
|
96 |
94 |
$463.89 |
| 99212 |
|
19 |
18 |
$438.38 |
| 99306 |
Prolong nursin fac eval 15m |
15 |
13 |
$420.09 |
| 73630 |
|
144 |
137 |
$396.34 |
| 99239 |
|
62 |
60 |
$328.90 |
| 11721 |
|
38 |
38 |
$317.64 |
| 73030 |
|
52 |
51 |
$308.72 |
| 77067 |
|
131 |
131 |
$256.81 |
| 20610 |
|
12 |
12 |
$255.33 |
| 72125 |
|
12 |
12 |
$245.64 |
| 72100 |
|
25 |
25 |
$121.30 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,442 |
1,151 |
$102.72 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
13 |
12 |
$24.16 |
| 74018 |
|
19 |
13 |
$16.15 |
| 81003 |
|
147 |
134 |
$11.67 |
| 93356 |
|
12 |
12 |
$6.93 |
| 36415 |
|
30 |
26 |
$3.00 |
| 73502 |
|
14 |
13 |
$2.00 |
| 84165 |
|
12 |
12 |
$1.89 |
| G0008 |
Administration of influenza virus vaccine |
119 |
119 |
$0.00 |
| 90662 |
|
107 |
107 |
$0.00 |